Global oncology information systems market was valued at $2.62 billion in 2017 and is estimated to reach $4.56 billion by 2025, registering a CAGR of 7.1% from 2018 to 2025.
Oncology information systems enable management of patient profiles by combining surgical, radiation, and medical oncology information in one system. Moreover, these systems facilitate management of treatment plans and schedules of cancer patients, and predict the results of the treatments. Safety and efficiency of cancer treatment is improved by use of these systems owing to their ability to predict the treatment outcome.
Key Benefits: -
The report presents the market analysis of the global Oncology Information System Market along with the regional trend and future estimations
It provides extensive information about the market segments from 2019 to 2027 to understand the market dynamics.
The key factors that drive, hamper, or provide opportunities to the market are provided in the report.
Competitive landscape of the industry along with the profile analysis of market players is provided in the report.
The key companies:
- Accuray Incorporated
- Bogardus Medical Systems, Inc.
- Cerner Corporation
- CureMD Corporation
- Elekta AB, Flatiron Health, Inc.
- Koninklijke Philips N.V.
- McKesson Corporation
- RaySearch Laboratories AB
- Varian Medical Systems, Inc.
Among end users, the hospitals & oncology clinics segment accounted for 95% of the total market share in 2017 and would maintain its dominance through 2025. This is because most of the population prefer going to hospitals for treatment due to ease of access and host of treatment options under one roof. The oncology unit at elite hospitals are equipped with different oncology information systems that focus on improving efficiency and offering support-specific clinical and workflow needs of patients and clinicians, respectively. However, the research centers segment is projected to grow at the fastest CAGR of 9.2% during the study period, as scientists and researchers across the globe, especially in developed countries, have been conducting research on cancer due to its increased disease burden.
Among product and services, the software segment contributed 81% share of total market revenue in 2017 and would retain its lead position through 2025. In addition, this segment is projected to grow at the fastest CAGR of 7.2% from 2018 to 2025 due to the higher adoption of oncology information system software among physicians to improve the management of patient information. The report also includes the analysis of the services segment.
0 Comments